GENEVA, Feb. 18 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2024/011844) for "NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER OR TUMORS COMPRISING SAME" on Aug 09, 2024. With publication no. WO/2025/034034, the details related to the patent application was published on Feb 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Int...